Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled Furosemide for Dyspnoea Relief (FurosAH)
NCT02881866Phase 1Completed
- Sponsor
- Oxford Brookes University
- Start
- Oct 2015
- Primary completion
- Mar 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of furosemide in Dyspnea, sponsored by Oxford Brookes University. Primary endpoint: Visual Analogue Scale at 20 minutes. Started Oct 2015; status: completed.
02
Drugs
furosemide
03
Conditions
Dyspnea
Beyond the preview
Go deeper on NCT02881866.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02881866.